Centers for Disease Control and Prevention (CDC)
1600 Clifton Road
Atlanta
Georgia
30333
United States
Tel: 404-639-3311
Website: http://www.cdc.gov/
Email: netinfo@cdc.gov
476 articles with Centers for Disease Control and Prevention (CDC)
-
Perspecta Awarded Contract with the Centers for Disease Control and Prevention to Benefit Public Health
12/11/2018
Perspecta Inc. announced today that it was awarded a prime contract on the Centers for Disease Control and Prevention's (CDC) Geospatial Research, Analysis, and Services Program (GRASP).
-
The American Foundation for Suicide Prevention: Suicide Rate is Up 3.7 Percent According to Most Recent Center for Disease Control and Prevention Data (Year 2017)
11/29/2018
Massive Public Health Initiative Needed to Lower the Suicide Rate, Claims Nation's Largest Suicide Prevention Organization
-
Yoga declared “most popular complementary health approach” in US by Centers for Disease Control
11/10/2018
“Yoga is the most popular complementary health approach in the United States - used by 14.3% of the adult population, or 35.2 million people”, according to a statement published on Centers for Disease Control and Prevention (CDC) website on November eight quoting National Health Interview Survey (NHIS).
-
Tick-Borne Disease Antigens for Commercial Assay Development
11/8/2018
The number of tick-borne related illnesses have increased significantly in the last decade. According to the CDC, there has been a three-fold increase in disease cases from infected mosquitos, ticks and fleas in the US from 2004 to 2016.
-
There are no treatments for autism, but that’s not stopping research into the development of therapies for core symptoms of autism spectrum disorder. This week, London-based AMO Pharma reported Phase II results from its investigational glycogen synthase kinase 3 (GSK3) beta inhibitor, AMO-02 (tid...
-
The Senate passed the bill on October 3 in a 98 to 1 vote. The House passed its version a week earlier in a vote of 393 to 8. The legislation includes provisions to promote research into new pain management drugs and expands access to substance abuse treatment for Medicaid patients.
-
Qpex Biopharma, a company spun-out of The Medicines Company focused on the development of anti-infective assets, launched this morning supported by a $33 million Series A financing round and a BARDA contract worth up to $132 million.
-
Again and again … and again, drugs have failed in clinical trials for Alzheimer’s disease. According to a new report, in the last decade, 146 drugs have failed in clinical trials for Alzheimer’s.
-
NIH Awards Grant to Battle Sepsis to San Diego's Allele Biotechnology and Pharmaceuticals
10/15/2018
The National Institute of General Medical Sciences, part of the National Institutes of Health, awarded Allele Biotechnology and Pharmaceuticals a Small Business Innovative Research grant to develop therapies for sepsis. -
Politicians might deny climate change, but disease-carrying insects and their pathogens aren’t—they’re exploiting it.
-
Rise of syphilis in newborns another symptom of nation's STD crisis
9/25/2018
NCSD calls for federal action to address increasing burden of STDs and their devastating consequences
-
Incidence of Alzheimer’s disease is projected to double in the next 40 years unless a cure or preventive measures are found. The U.S. Centers for Disease Control and Prevention published a new report in the journal Alzheimer’s & Dementia projecting the disease’s likely expansion, and for the firs...
-
As federal lawmakers continue to wrangle over legislation to help curb the opioid crisis in the United States, the House of Representatives is showing some division over the costs that some pharmaceutical companies may have to pay for Medicare coverage.
-
In a 99 to 1 vote, the Senate passed the bill that looks to cut down on the flow of illegal narcotics entering the United States through the mail, as well as taking aim at the abuse of prescription opioid medication – a problem that has grown to an epidemic in the United States.
-
U.S. Food and Drug Administration (FDA) Commissioner Scott Gottlieb gave a talk at The Pew Charitable Trusts on Friday, September 14, outlining the agency’s new approach to dealing with antimicrobial resistance (AMR).
-
Last year’s influenza season in the U.S. had record-breaking hospitalization rates. A lot of industry observers are looking at a new flu drug, baloxavir marboxil, for which clinical trial data was just published.
-
Holland America Line's Amsterdam and Noordam Earn Perfect Scores of 100 on United States Public Health Inspection
9/12/2018
Ships add to company's record of 29 perfect scores over the past five years
-
The U.S. Food and Drug Administration is hoping to fill numerous vacancies at the regulatory agency. In June, the FDA laid out some of its hiring needs, as well as its approach to attracting top-quality talent in a report to Congress.
-
Once again, Amgen is accepting submissions for the 2018 Amgen-LabCentral Golden Ticket competition.
-
CDC Awards BioCryst $35 Million RAPIVAB® Contract for Strategic National Stockpile
9/10/2018
BioCryst Pharmaceuticals, Inc. today announced that the Centers for Disease Control and Prevention (CDC) has awarded BioCryst a $34.7 million contract for the procurement of up to 50,000 doses of BioCryst’s approved antiviral influenza therapy, RAPIVAB® (peramivir injection) over a five-year period.